• 1. An apparatus for determining small amounts of alchohol in sour milk and urine
  Analyst, 1964,89, 272-275
• 2. An aptamer-based keypad lock system?
  Yaqing Liu,Jiangtao Ren,Jing Li,Jiyang Liu,Erkang Wang Chem. Commun., 2012,48, 802-804
• 3. An investigation of the electrochemical delithiation process of carbon coated α-Fe2O3nanoparticles
  Adrian Brandt,Florian Winter,Sebastian Klamor,Frank Berkemeier,Jatinkumar Rana,Rainer P?ttgen,Andrea Balducci J. Mater. Chem. A, 2013,1, 11229-11236
• 4. An automated in-chip-catalytic–spectrophotometric method for determination of copper(ii) using a multisyringe flow injection analysis-multipumping flow system?
  Camelia Henríquez,Edwin Palacio,Víctor Cerdà Anal. Methods, 2014,6, 8494-8504
• 5. An approach to C–N activation: coupling of arenesulfonyl hydrazides and arenesulfonyl chlorides with tert-amines via a metal-, oxidant- and halogen-free anodic oxidation??
  M. Sheykhan,S. Khani,S. Shaabanzadeh,M. Joafshan Green Chem., 2017,19, 5940-5948

Introduction to 2,5-dimethyl-4-nitropyridin-1-ium-1-olate (CAS No. 21816-42-2)

2,5-dimethyl-4-nitropyridin-1-ium-1-olate, identified by the Chemical Abstracts Service Number (CAS No.) 21816-42-2, is a specialized chemical compound that has garnered significant attention in the field of pharmaceutical chemistry and medicinal biology. This compound belongs to the class of nitropyridine derivatives, which are widely recognized for their diverse pharmacological properties and potential applications in drug discovery. The structural uniqueness of 2,5-dimethyl-4-nitropyridin-1-ium-1-olate lies in its nitro-substituted pyridine core, which is further modified by methyl groups at the 2nd and 5th positions, enhancing its reactivity and functional versatility.

The nitro group in the molecular structure of this compound plays a pivotal role in its chemical behavior, influencing both its reactivity and its interaction with biological targets. The presence of the nitro group allows for various chemical transformations, including reduction to an amine or diazotization, which can be exploited in synthetic pathways for more complex molecules. Additionally, the electron-withdrawing nature of the nitro group can modulate the electronic properties of the pyridine ring, making it a valuable scaffold for designing molecules with specific biological activities.

Recent advancements in medicinal chemistry have highlighted the importance of nitropyridine derivatives in the development of novel therapeutic agents. Studies have demonstrated that compounds featuring a nitro-pyridine moiety often exhibit potent activity against a range of targets, including enzymes and receptors involved in inflammatory responses, bacterial infections, and even certain types of cancer. The dimethyl substitution at the 2nd and 5th positions in 2,5-dimethyl-4-nitropyridin-1-ium-1-olate further fine-tunes its pharmacokinetic properties, potentially improving solubility and metabolic stability.

In particular, research has shown that nitropyridines can serve as versatile intermediates in the synthesis of bioactive molecules. The ability to functionalize the pyridine ring at multiple positions allows for the creation of libraries of compounds with tailored properties. For instance, derivatives of 2,5-dimethyl-4-nitropyridin-1-ium-1-olate have been explored as inhibitors of enzymes such as cyclooxygenase (COX) and lipoxygenase (LOX), which are key players in inflammation. The structural motif is also being investigated for its potential in targeting bacterial enzymes that contribute to antibiotic resistance.

The oleate salt form (indicated by "-olate" in the name) is particularly noteworthy as it enhances the solubility and bioavailability of the compound. This formulation is crucial for ensuring efficient delivery to biological targets, whether in preclinical studies or potential clinical applications. The use of fatty acid salts like oleate is a common strategy in pharmaceutical chemistry to improve membrane permeability and target specificity.

Current research trends indicate that nitropyridine derivatives are being increasingly utilized in combination therapies. The multifaceted interactions offered by these compounds make them suitable candidates for synergistic approaches in treating complex diseases. For example, studies have suggested that combining a nitropyridine-based inhibitor with other therapeutic agents could lead to enhanced efficacy while minimizing side effects. This underscores the need for comprehensive structural optimization to maximize therapeutic benefits.

The synthesis of 2,5-dimethyl-4-nitropyridin-1-ium-1-olate involves multi-step organic transformations that require precise control over reaction conditions. Advanced synthetic methodologies, including transition metal-catalyzed cross-coupling reactions and palladium-mediated transformations, have been employed to achieve high yields and purity. These techniques are essential for producing sufficient quantities of the compound for both research purposes and potential pharmaceutical development.

From a computational chemistry perspective, molecular modeling studies have been instrumental in understanding the binding interactions of 2,5-dimethyl-4-nitropyridin-1-ium-1-olate with biological targets. These studies help predict binding affinities and optimize lead structures before experimental validation. The integration of machine learning algorithms has further accelerated this process by enabling rapid screening of virtual libraries derived from similar scaffolds.

The safety profile of 2,5-dimethyl-4-nitropyridin-1-ium-1-olate is another critical aspect that has been thoroughly evaluated through preclinical studies. Toxicological assessments have focused on determining acceptable exposure levels and identifying any potential adverse effects. These evaluations are essential steps before moving into clinical trials and ensure that any potential therapeutic benefits outweigh risks associated with long-term use.

Future directions in research may explore novel derivatives of 2,5-dimethyl-4-nitropyridin-1-ium-1-olate by modifying additional functional groups or exploring different salt forms. Such modifications could lead to improved pharmacological properties or new applications in areas such as neurology or immunotherapy. Collaborative efforts between synthetic chemists and biologists will be crucial in translating these findings into tangible therapeutic advances.

In conclusion,2,5-dimethyl-NitroPyridiniumOleate (CAS No: 21816–42–2) represents a promising compound with significant potential in pharmaceutical research. Its unique structural features combined with recent advancements in synthetic chemistry make it an attractive candidate for further exploration. As our understanding of its biological activities grows, this molecule is poised to contribute valuable insights into drug discovery efforts aimed at addressing unmet medical needs.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)